BioRestorative Therapies, Inc. (BRTX) NASDAQ

1.80

-0.0194(-1.07%)

Updated at May 09 10:53AM

Currency In USD

Valuation

Market Cap11.1M
Enterprise Value10.55M
P/E Ratio-1.39
PEG Ratio0.02
Price/Sales Ratio33.71
Price/Book Ratio1.46
Enterprise/Revenue32.34
Enterprise/EBITDA-1.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-22.39
Operating Margin-28.82

Management Effectiveness

Return On Assets-0.73
Return On Equity-0.82

Income Statement

Revenue401,000
Revenue/Share0.06
Gross Profit372,928
EBITDA-11.56M
Net Income-8.98M
Diluted EPS-1.16

Balance Sheet

Total Cash10.73M
Total Cash/Share1.55
Total Debt0
Total Debt/Equity0
Current Ratio2.97
Book Value Per Share1.23

Price History

52-Week Change25.96
52-Week High2.55
52-Week Low1.03
Moving Average 50 Days1.72
Moving Average 200 Days1.7

Statistics

Average Volume372,375
Shares Outstanding7.5M
% Held by Institutions3.47

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor1:4000
Last Split DateOctober 27, 2021